HIT Consultant October 10, 2024
What You Should Know:
– clock.bio, a healthspan biotechnology company based at the Milner Therapeutics Institute in Cambridge, has secured $5.3M in seed funding to advance its groundbreaking research on human rejuvenation.
– The seed funding round was led by LocalGlobe, with participation from BlueYard Capital, Onsight Ventures, and Dr. Jonathan Milner, the Founder of Abcam.
Decoding the Secrets of Cellular Rejuvenation
clock.bio has developed a proprietary aging model using human induced pluripotent stem cells (iPSCs). By forcing these stem cells to age, the researchers can observe and analyze the natural rejuvenation mechanisms that restore the cells to a youthful state.
Through a genome-wide CRISPR screen and single-cell RNA sequencing, clock.bio has identified over 100 genes that play...
Today's Sponsors
Today's Sponsor